Hoth Therapeutics is progressing HT-KIT towards clinical evaluation, aiming to submit an investigational new drug application to the FDA in early 2026. An investigational new drug application is a request for FDA authorization to administer an investigational drug to patients. This step is crucial before administering any new drug not yet approved through a new […]
Category: gene silencing
Vivodyne’s $40M Boost for Animal Testing Alternatives
Vivodyne, a biotech company, has secured $40 million in funding to further their research on animal testing alternatives. Led by Huh and Georgescu, their innovative system merges robotics and AI to enhance preclinical drug development, aiming to revolutionize the field. This investment signifies a significant step towards more ethical and effective testing methods in biotechnology, […]
Gene-Silencing Therapy for Chronic Pain in Osteoarthritis
In a groundbreaking initiative to combat the chronic pain associated with osteoarthritis, Dr Caroline Aylott, Head of Research Delivery at Versus Arthritis, underscores the pressing need for innovative solutions. With millions of osteoarthritis sufferers enduring daily agony and limited treatment options, this project aligns with the Early Detection and Targeted Treatments priority funding call. The […]
